The efficacy and safety of combined tiotropium and olodaterol via the Respimat(®) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado(®) studies

BACKGROUND: The efficacy and safety of once-daily tiotropium + olodaterol (T+O) maintenance treatment was demonstrated in the large, multinational, replicate, randomized, Phase III, Tonado(®) 1 (NCT01431274) and 2 (NCT01431287) studies in patients with moderate to very severe COPD. However, there ma...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Chron Obstruct Pulmon Dis
Главные авторы: Ichinose, Masakazu, Taniguchi, Hiroyuki, Takizawa, Ayako, Grönke, Lars, Loaiza, Lazaro, Voß, Florian, Zhao, Yihua, Fukuchi, Yoshinosuke
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2016
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5010080/
https://ncbi.nlm.nih.gov/pubmed/27621608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S110389
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы